Experts gathered in central China's Wuhan City on Thursday for a conference to advance new quality productive forces through science and technological innovation.
The conference saw experts from politics, academia, health and technology sectors in attendance.
The chairman of a biomedicine giant presented a groundbreaking technology for extracting recombinant human serum albumin from rice. He emphasized that the medicine has traditionally been derived from human plasma for over 80 years, and this new technology offers a novel approach for the biopharmaceutical industry.
"The whole world wants to use this (plant extraction) as a substitute for plasma (extraction), but they haven't been successful. So we used the latest plant system and the most challenging variety. Our efforts have spanned nearly 19 years," said Yang Daichang, chairman of the Wuhan Healthgen Biotechnology Corp.
Another company, specializing in smart sensors, introduced cutting-edge technological applications in smart electronics and intelligent sensing.
"We have now implemented the industry's highest-precision, fully-printed electronics technologies for humanoid robots, offering it a better sense of touch," said Zhu Xiaohui, general manager of the Wuhan Huaweike Intelligent Technology Co.
In recent years, Wuhan has ramped up mechanisms for fostering new quality productive forces in line with local conditions, successfully attracting a significant number of scientific and technological firms.
The 2024 Global Innovation Index Report by the World Intellectual Property Organization ranked Wuhan 13th in the world and 5th in China. From January to August of this year, the added value of Wuhan's high-tech manufacturing sector above the designated size surged by 31.8 percent. The new growth drivers and industries are emerging as powerful engines of economic growth.
"Wuhan's inclusiveness and responsibility are great, and many new problems can be solved in time," said He Enpei, chairman of the Transn Internet of Languages Technology Co.